Moreover, insulin resistance and hyperinsulinemia have been shown to be associated with an increased risk of EP, and may contribute to the pathogenesis of other endometrial disorders such as endometrial hyperplasia and endometrial cancer through insulin receptor interactions on the surface of cell membranes [13–16]. The gene discussed is INSR; the disease is Insulin resistance.